CD8A and HIV infectious disease: In individuals with primary HIV infection, KTR at baseline was positively associated with the reduction in proportion of CD8 + CD38 + HLA-DR+ T cells after 6 (ρ .833, p = 0.010) and 12 months of cART (ρ.900, p = 0.037).